chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Computerised tomogram head abnormal, Dysarthria, EGFR status assay, Eosinophil count decreased
Clinical narrative: 67 yo female with PMH of HTN, DM who has two days of left sided numbness that has progressed to left hemiparesis and dysarthria in the setting of having received the Johnson and Johnson vaccine on Wednesday(48hours prior). Patient was found to have a right parietal multifocal parenchymal hemorrhage measuring 19x36x37mm and small right temporal lobe SAH. Subsequent CTA showed thrombosis of the superior sagittal sinus and the right frontoparietal cortical veins as well has nonocclusive thrombus of right transverse and sigmoid sinus. The patient was also noted to have focal seizure of mouth and tongue and was loaded with phosphenytoin. After discussing case with neurology, nuero IR, NSGY and family it was decided to transfer the patient to sunrise for close monitoring and consideration of cerebral venous sinus thrombectomy if she worsens. I had a long discussion with multiple sisters about the risks of anticoagulation with argatroban given the IPH but the necessity given the cerebral venous thrombosis. I also discussed that argatroban is not readily reversible and that heparin is contraindicated if there is concern about vaccine induced thrombotic thrombocytopenia due to possible PF4 ab related to HIT. The patients VITT modified 4T score is 4 and she is intermediate risk for this being VITT. #Right parietal IPH, right temporal SAH and Superior saggital sinus thrombosis with nonocclusive thrombus of right transverse and sigmoid sinus -concern for vaccine induced thrombotic thrombocytopenia given johnson and johnson vaccine 2 days prior -modified VITT 4T score of 4- intermediate -send fibrinogen, d dimer, consider IVIG 1gm/kg per day for two days if high dimer, low fibrinogen and falling platelets -will start argatroban, avoid heparin until HIT ab (PF4) is resulted, if HIT positive avoid heparin -neuro IR consulted for possible IR intervention if worsens -transfer accepted by sunrise ICU, appreciate transfer for IR evaluation -continue phosphenytoin -SBP goal <150 with nicardipine and esmolol gtts -monitor daily fibrinogen, dimer, coags #AKI- monitoring uop and cr, consider renal US if worsens #DM- ISS #HTN- nicardipine and esmolol gtts for SBP <150, target 140 Patient seen, examined, labs and imaging reviewed, agree with resident note
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eosinophil percentage, Facial paralysis, Fibrin D dimer normal, Haematocrit normal, Haemoglobin normal
Clinical narrative: 67 yo female with PMH of HTN, DM who has two days of left sided numbness that has progressed to left hemiparesis and dysarthria in the setting of having received the Johnson and Johnson vaccine on Wednesday(48hours prior). Patient was found to have a right parietal multifocal parenchymal hemorrhage measuring 19x36x37mm and small right temporal lobe SAH. Subsequent CTA showed thrombosis of the superior sagittal sinus and the right frontoparietal cortical veins as well has nonocclusive thrombus of right transverse and sigmoid sinus. The patient was also noted to have focal seizure of mouth and tongue and was loaded with phosphenytoin. After discussing case with neurology, nuero IR, NSGY and family it was decided to transfer the patient to sunrise for close monitoring and consideration of cerebral venous sinus thrombectomy if she worsens. I had a long discussion with multiple sisters about the risks of anticoagulation with argatroban given the IPH but the necessity given the cerebral venous thrombosis. I also discussed that argatroban is not readily reversible and that heparin is contraindicated if there is concern about vaccine induced thrombotic thrombocytopenia due to possible PF4 ab related to HIT. The patients VITT modified 4T score is 4 and she is intermediate risk for this being VITT. #Right parietal IPH, right temporal SAH and Superior saggital sinus thrombosis with nonocclusive thrombus of right transverse and sigmoid sinus -concern for vaccine induced thrombotic thrombocytopenia given johnson and johnson vaccine 2 days prior -modified VITT 4T score of 4- intermediate -send fibrinogen, d dimer, consider IVIG 1gm/kg per day for two days if high dimer, low fibrinogen and falling platelets -will start argatroban, avoid heparin until HIT ab (PF4) is resulted, if HIT positive avoid heparin -neuro IR consulted for possible IR intervention if worsens -transfer accepted by sunrise ICU, appreciate transfer for IR evaluation -continue phosphenytoin -SBP goal <150 with nicardipine and esmolol gtts -monitor daily fibrinogen, dimer, coags #AKI- monitoring uop and cr, consider renal US if worsens #DM- ISS #HTN- nicardipine and esmolol gtts for SBP <150, target 140 Patient seen, examined, labs and imaging reviewed, agree with resident note
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hemiparesis, Heparin-induced thrombocytopenia test, Hypoaesthesia, Immature granulocyte count, Intensive care
Clinical narrative: 67 yo female with PMH of HTN, DM who has two days of left sided numbness that has progressed to left hemiparesis and dysarthria in the setting of having received the Johnson and Johnson vaccine on Wednesday(48hours prior). Patient was found to have a right parietal multifocal parenchymal hemorrhage measuring 19x36x37mm and small right temporal lobe SAH. Subsequent CTA showed thrombosis of the superior sagittal sinus and the right frontoparietal cortical veins as well has nonocclusive thrombus of right transverse and sigmoid sinus. The patient was also noted to have focal seizure of mouth and tongue and was loaded with phosphenytoin. After discussing case with neurology, nuero IR, NSGY and family it was decided to transfer the patient to sunrise for close monitoring and consideration of cerebral venous sinus thrombectomy if she worsens. I had a long discussion with multiple sisters about the risks of anticoagulation with argatroban given the IPH but the necessity given the cerebral venous thrombosis. I also discussed that argatroban is not readily reversible and that heparin is contraindicated if there is concern about vaccine induced thrombotic thrombocytopenia due to possible PF4 ab related to HIT. The patients VITT modified 4T score is 4 and she is intermediate risk for this being VITT. #Right parietal IPH, right temporal SAH and Superior saggital sinus thrombosis with nonocclusive thrombus of right transverse and sigmoid sinus -concern for vaccine induced thrombotic thrombocytopenia given johnson and johnson vaccine 2 days prior -modified VITT 4T score of 4- intermediate -send fibrinogen, d dimer, consider IVIG 1gm/kg per day for two days if high dimer, low fibrinogen and falling platelets -will start argatroban, avoid heparin until HIT ab (PF4) is resulted, if HIT positive avoid heparin -neuro IR consulted for possible IR intervention if worsens -transfer accepted by sunrise ICU, appreciate transfer for IR evaluation -continue phosphenytoin -SBP goal <150 with nicardipine and esmolol gtts -monitor daily fibrinogen, dimer, coags #AKI- monitoring uop and cr, consider renal US if worsens #DM- ISS #HTN- nicardipine and esmolol gtts for SBP <150, target 140 Patient seen, examined, labs and imaging reviewed, agree with resident note
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: International normalised ratio normal, Lymphocyte count, Lymphocyte count normal, Mean cell haemoglobin concentration decreased, Mean cell haemoglobin normal
Clinical narrative: 67 yo female with PMH of HTN, DM who has two days of left sided numbness that has progressed to left hemiparesis and dysarthria in the setting of having received the Johnson and Johnson vaccine on Wednesday(48hours prior). Patient was found to have a right parietal multifocal parenchymal hemorrhage measuring 19x36x37mm and small right temporal lobe SAH. Subsequent CTA showed thrombosis of the superior sagittal sinus and the right frontoparietal cortical veins as well has nonocclusive thrombus of right transverse and sigmoid sinus. The patient was also noted to have focal seizure of mouth and tongue and was loaded with phosphenytoin. After discussing case with neurology, nuero IR, NSGY and family it was decided to transfer the patient to sunrise for close monitoring and consideration of cerebral venous sinus thrombectomy if she worsens. I had a long discussion with multiple sisters about the risks of anticoagulation with argatroban given the IPH but the necessity given the cerebral venous thrombosis. I also discussed that argatroban is not readily reversible and that heparin is contraindicated if there is concern about vaccine induced thrombotic thrombocytopenia due to possible PF4 ab related to HIT. The patients VITT modified 4T score is 4 and she is intermediate risk for this being VITT. #Right parietal IPH, right temporal SAH and Superior saggital sinus thrombosis with nonocclusive thrombus of right transverse and sigmoid sinus -concern for vaccine induced thrombotic thrombocytopenia given johnson and johnson vaccine 2 days prior -modified VITT 4T score of 4- intermediate -send fibrinogen, d dimer, consider IVIG 1gm/kg per day for two days if high dimer, low fibrinogen and falling platelets -will start argatroban, avoid heparin until HIT ab (PF4) is resulted, if HIT positive avoid heparin -neuro IR consulted for possible IR intervention if worsens -transfer accepted by sunrise ICU, appreciate transfer for IR evaluation -continue phosphenytoin -SBP goal <150 with nicardipine and esmolol gtts -monitor daily fibrinogen, dimer, coags #AKI- monitoring uop and cr, consider renal US if worsens #DM- ISS #HTN- nicardipine and esmolol gtts for SBP <150, target 140 Patient seen, examined, labs and imaging reviewed, agree with resident note
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mean cell volume normal, Mean platelet volume normal, Meige's syndrome, Monocyte count increased, Monocyte percentage increased
Clinical narrative: 67 yo female with PMH of HTN, DM who has two days of left sided numbness that has progressed to left hemiparesis and dysarthria in the setting of having received the Johnson and Johnson vaccine on Wednesday(48hours prior). Patient was found to have a right parietal multifocal parenchymal hemorrhage measuring 19x36x37mm and small right temporal lobe SAH. Subsequent CTA showed thrombosis of the superior sagittal sinus and the right frontoparietal cortical veins as well has nonocclusive thrombus of right transverse and sigmoid sinus. The patient was also noted to have focal seizure of mouth and tongue and was loaded with phosphenytoin. After discussing case with neurology, nuero IR, NSGY and family it was decided to transfer the patient to sunrise for close monitoring and consideration of cerebral venous sinus thrombectomy if she worsens. I had a long discussion with multiple sisters about the risks of anticoagulation with argatroban given the IPH but the necessity given the cerebral venous thrombosis. I also discussed that argatroban is not readily reversible and that heparin is contraindicated if there is concern about vaccine induced thrombotic thrombocytopenia due to possible PF4 ab related to HIT. The patients VITT modified 4T score is 4 and she is intermediate risk for this being VITT. #Right parietal IPH, right temporal SAH and Superior saggital sinus thrombosis with nonocclusive thrombus of right transverse and sigmoid sinus -concern for vaccine induced thrombotic thrombocytopenia given johnson and johnson vaccine 2 days prior -modified VITT 4T score of 4- intermediate -send fibrinogen, d dimer, consider IVIG 1gm/kg per day for two days if high dimer, low fibrinogen and falling platelets -will start argatroban, avoid heparin until HIT ab (PF4) is resulted, if HIT positive avoid heparin -neuro IR consulted for possible IR intervention if worsens -transfer accepted by sunrise ICU, appreciate transfer for IR evaluation -continue phosphenytoin -SBP goal <150 with nicardipine and esmolol gtts -monitor daily fibrinogen, dimer, coags #AKI- monitoring uop and cr, consider renal US if worsens #DM- ISS #HTN- nicardipine and esmolol gtts for SBP <150, target 140 Patient seen, examined, labs and imaging reviewed, agree with resident note
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neutrophil count, Neutrophil percentage, Partial seizures, Platelet count increased, Protein total normal
Clinical narrative: 67 yo female with PMH of HTN, DM who has two days of left sided numbness that has progressed to left hemiparesis and dysarthria in the setting of having received the Johnson and Johnson vaccine on Wednesday(48hours prior). Patient was found to have a right parietal multifocal parenchymal hemorrhage measuring 19x36x37mm and small right temporal lobe SAH. Subsequent CTA showed thrombosis of the superior sagittal sinus and the right frontoparietal cortical veins as well has nonocclusive thrombus of right transverse and sigmoid sinus. The patient was also noted to have focal seizure of mouth and tongue and was loaded with phosphenytoin. After discussing case with neurology, nuero IR, NSGY and family it was decided to transfer the patient to sunrise for close monitoring and consideration of cerebral venous sinus thrombectomy if she worsens. I had a long discussion with multiple sisters about the risks of anticoagulation with argatroban given the IPH but the necessity given the cerebral venous thrombosis. I also discussed that argatroban is not readily reversible and that heparin is contraindicated if there is concern about vaccine induced thrombotic thrombocytopenia due to possible PF4 ab related to HIT. The patients VITT modified 4T score is 4 and she is intermediate risk for this being VITT. #Right parietal IPH, right temporal SAH and Superior saggital sinus thrombosis with nonocclusive thrombus of right transverse and sigmoid sinus -concern for vaccine induced thrombotic thrombocytopenia given johnson and johnson vaccine 2 days prior -modified VITT 4T score of 4- intermediate -send fibrinogen, d dimer, consider IVIG 1gm/kg per day for two days if high dimer, low fibrinogen and falling platelets -will start argatroban, avoid heparin until HIT ab (PF4) is resulted, if HIT positive avoid heparin -neuro IR consulted for possible IR intervention if worsens -transfer accepted by sunrise ICU, appreciate transfer for IR evaluation -continue phosphenytoin -SBP goal <150 with nicardipine and esmolol gtts -monitor daily fibrinogen, dimer, coags #AKI- monitoring uop and cr, consider renal US if worsens #DM- ISS #HTN- nicardipine and esmolol gtts for SBP <150, target 140 Patient seen, examined, labs and imaging reviewed, agree with resident note
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Prothrombin time normal, Red blood cell count normal, Red blood cell nucleated morphology, Red cell distribution width normal, Scan with contrast abnormal
Clinical narrative: 67 yo female with PMH of HTN, DM who has two days of left sided numbness that has progressed to left hemiparesis and dysarthria in the setting of having received the Johnson and Johnson vaccine on Wednesday(48hours prior). Patient was found to have a right parietal multifocal parenchymal hemorrhage measuring 19x36x37mm and small right temporal lobe SAH. Subsequent CTA showed thrombosis of the superior sagittal sinus and the right frontoparietal cortical veins as well has nonocclusive thrombus of right transverse and sigmoid sinus. The patient was also noted to have focal seizure of mouth and tongue and was loaded with phosphenytoin. After discussing case with neurology, nuero IR, NSGY and family it was decided to transfer the patient to sunrise for close monitoring and consideration of cerebral venous sinus thrombectomy if she worsens. I had a long discussion with multiple sisters about the risks of anticoagulation with argatroban given the IPH but the necessity given the cerebral venous thrombosis. I also discussed that argatroban is not readily reversible and that heparin is contraindicated if there is concern about vaccine induced thrombotic thrombocytopenia due to possible PF4 ab related to HIT. The patients VITT modified 4T score is 4 and she is intermediate risk for this being VITT. #Right parietal IPH, right temporal SAH and Superior saggital sinus thrombosis with nonocclusive thrombus of right transverse and sigmoid sinus -concern for vaccine induced thrombotic thrombocytopenia given johnson and johnson vaccine 2 days prior -modified VITT 4T score of 4- intermediate -send fibrinogen, d dimer, consider IVIG 1gm/kg per day for two days if high dimer, low fibrinogen and falling platelets -will start argatroban, avoid heparin until HIT ab (PF4) is resulted, if HIT positive avoid heparin -neuro IR consulted for possible IR intervention if worsens -transfer accepted by sunrise ICU, appreciate transfer for IR evaluation -continue phosphenytoin -SBP goal <150 with nicardipine and esmolol gtts -monitor daily fibrinogen, dimer, coags #AKI- monitoring uop and cr, consider renal US if worsens #DM- ISS #HTN- nicardipine and esmolol gtts for SBP <150, target 140 Patient seen, examined, labs and imaging reviewed, agree with resident note
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Subarachnoid haemorrhage, Superior sagittal sinus thrombosis, Tachycardia, Thyroid mass, Tongue movement disturbance
Clinical narrative: 67 yo female with PMH of HTN, DM who has two days of left sided numbness that has progressed to left hemiparesis and dysarthria in the setting of having received the Johnson and Johnson vaccine on Wednesday(48hours prior). Patient was found to have a right parietal multifocal parenchymal hemorrhage measuring 19x36x37mm and small right temporal lobe SAH. Subsequent CTA showed thrombosis of the superior sagittal sinus and the right frontoparietal cortical veins as well has nonocclusive thrombus of right transverse and sigmoid sinus. The patient was also noted to have focal seizure of mouth and tongue and was loaded with phosphenytoin. After discussing case with neurology, nuero IR, NSGY and family it was decided to transfer the patient to sunrise for close monitoring and consideration of cerebral venous sinus thrombectomy if she worsens. I had a long discussion with multiple sisters about the risks of anticoagulation with argatroban given the IPH but the necessity given the cerebral venous thrombosis. I also discussed that argatroban is not readily reversible and that heparin is contraindicated if there is concern about vaccine induced thrombotic thrombocytopenia due to possible PF4 ab related to HIT. The patients VITT modified 4T score is 4 and she is intermediate risk for this being VITT. #Right parietal IPH, right temporal SAH and Superior saggital sinus thrombosis with nonocclusive thrombus of right transverse and sigmoid sinus -concern for vaccine induced thrombotic thrombocytopenia given johnson and johnson vaccine 2 days prior -modified VITT 4T score of 4- intermediate -send fibrinogen, d dimer, consider IVIG 1gm/kg per day for two days if high dimer, low fibrinogen and falling platelets -will start argatroban, avoid heparin until HIT ab (PF4) is resulted, if HIT positive avoid heparin -neuro IR consulted for possible IR intervention if worsens -transfer accepted by sunrise ICU, appreciate transfer for IR evaluation -continue phosphenytoin -SBP goal <150 with nicardipine and esmolol gtts -monitor daily fibrinogen, dimer, coags #AKI- monitoring uop and cr, consider renal US if worsens #DM- ISS #HTN- nicardipine and esmolol gtts for SBP <150, target 140 Patient seen, examined, labs and imaging reviewed, agree with resident note
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Transverse sinus thrombosis, Troponin, White blood cell count increased
Clinical narrative: 67 yo female with PMH of HTN, DM who has two days of left sided numbness that has progressed to left hemiparesis and dysarthria in the setting of having received the Johnson and Johnson vaccine on Wednesday(48hours prior). Patient was found to have a right parietal multifocal parenchymal hemorrhage measuring 19x36x37mm and small right temporal lobe SAH. Subsequent CTA showed thrombosis of the superior sagittal sinus and the right frontoparietal cortical veins as well has nonocclusive thrombus of right transverse and sigmoid sinus. The patient was also noted to have focal seizure of mouth and tongue and was loaded with phosphenytoin. After discussing case with neurology, nuero IR, NSGY and family it was decided to transfer the patient to sunrise for close monitoring and consideration of cerebral venous sinus thrombectomy if she worsens. I had a long discussion with multiple sisters about the risks of anticoagulation with argatroban given the IPH but the necessity given the cerebral venous thrombosis. I also discussed that argatroban is not readily reversible and that heparin is contraindicated if there is concern about vaccine induced thrombotic thrombocytopenia due to possible PF4 ab related to HIT. The patients VITT modified 4T score is 4 and she is intermediate risk for this being VITT. #Right parietal IPH, right temporal SAH and Superior saggital sinus thrombosis with nonocclusive thrombus of right transverse and sigmoid sinus -concern for vaccine induced thrombotic thrombocytopenia given johnson and johnson vaccine 2 days prior -modified VITT 4T score of 4- intermediate -send fibrinogen, d dimer, consider IVIG 1gm/kg per day for two days if high dimer, low fibrinogen and falling platelets -will start argatroban, avoid heparin until HIT ab (PF4) is resulted, if HIT positive avoid heparin -neuro IR consulted for possible IR intervention if worsens -transfer accepted by sunrise ICU, appreciate transfer for IR evaluation -continue phosphenytoin -SBP goal <150 with nicardipine and esmolol gtts -monitor daily fibrinogen, dimer, coags #AKI- monitoring uop and cr, consider renal US if worsens #DM- ISS #HTN- nicardipine and esmolol gtts for SBP <150, target 140 Patient seen, examined, labs and imaging reviewed, agree with resident note
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebral venous thrombosis, Computerised tomogram head abnormal, Haemorrhagic stroke, Magnetic resonance imaging head abnormal, Venogram abnormal
Clinical narrative: 67 yo female with PMH of HTN, DM who has two days of left sided numbness that has progressed to left hemiparesis and dysarthria in the setting of having received the Johnson and Johnson vaccine on Wednesday(48hours prior). Patient was found to have a right parietal multifocal parenchymal hemorrhage measuring 19x36x37mm and small right temporal lobe SAH. Subsequent CTA showed thrombosis of the superior sagittal sinus and the right frontoparietal cortical veins as well has nonocclusive thrombus of right transverse and sigmoid sinus. The patient was also noted to have focal seizure of mouth and tongue and was loaded with phosphenytoin. After discussing case with neurology, nuero IR, NSGY and family it was decided to transfer the patient to sunrise for close monitoring and consideration of cerebral venous sinus thrombectomy if she worsens. I had a long discussion with multiple sisters about the risks of anticoagulation with argatroban given the IPH but the necessity given the cerebral venous thrombosis. I also discussed that argatroban is not readily reversible and that heparin is contraindicated if there is concern about vaccine induced thrombotic thrombocytopenia due to possible PF4 ab related to HIT. The patients VITT modified 4T score is 4 and she is intermediate risk for this being VITT. #Right parietal IPH, right temporal SAH and Superior saggital sinus thrombosis with nonocclusive thrombus of right transverse and sigmoid sinus -concern for vaccine induced thrombotic thrombocytopenia given johnson and johnson vaccine 2 days prior -modified VITT 4T score of 4- intermediate -send fibrinogen, d dimer, consider IVIG 1gm/kg per day for two days if high dimer, low fibrinogen and falling platelets -will start argatroban, avoid heparin until HIT ab (PF4) is resulted, if HIT positive avoid heparin -neuro IR consulted for possible IR intervention if worsens -transfer accepted by sunrise ICU, appreciate transfer for IR evaluation -continue phosphenytoin -SBP goal <150 with nicardipine and esmolol gtts -monitor daily fibrinogen, dimer, coags #AKI- monitoring uop and cr, consider renal US if worsens #DM- ISS #HTN- nicardipine and esmolol gtts for SBP <150, target 140 Patient seen, examined, labs and imaging reviewed, agree with resident note
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time shortened, Alanine aminotransferase increased, Albumin globulin ratio normal, Angiogram cerebral abnormal, Anion gap
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Arteriogram carotid normal, Aspartate aminotransferase increased, Bacterial test, Basophil count decreased
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Basophil percentage decreased, Blood albumin normal, Blood alkaline phosphatase normal, Blood bilirubin decreased, Blood calcium normal
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood chloride increased, Blood creatinine increased, Blood fibrinogen increased, Blood glucose increased, Blood potassium decreased
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood sodium normal, Blood urea normal, Carbon dioxide decreased, Cerebral haemorrhage, Cerebral venous thrombosis
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Computerised tomogram head abnormal, Dysarthria, EGFR status assay, Eosinophil count decreased
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eosinophil percentage, Facial paralysis, Fibrin D dimer normal, Haematocrit normal, Haemoglobin normal
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hemiparesis, Heparin-induced thrombocytopenia test, Hypoaesthesia, Immature granulocyte count, Intensive care
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: International normalised ratio normal, Lymphocyte count, Lymphocyte count normal, Mean cell haemoglobin concentration decreased, Mean cell haemoglobin normal
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mean cell volume normal, Mean platelet volume normal, Meige's syndrome, Monocyte count increased, Monocyte percentage increased
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neutrophil count, Neutrophil percentage, Partial seizures, Platelet count increased, Protein total normal
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Prothrombin time normal, Red blood cell count normal, Red blood cell nucleated morphology, Red cell distribution width normal, Scan with contrast abnormal
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Subarachnoid haemorrhage, Superior sagittal sinus thrombosis, Tachycardia, Thyroid mass, Tongue movement disturbance
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Transverse sinus thrombosis, Troponin, White blood cell count increased
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebral venous thrombosis, Computerised tomogram head abnormal, Haemorrhagic stroke, Magnetic resonance imaging head abnormal, Venogram abnormal
Clinical narrative: cerebral venous thrombosis; hemorrhagic strokes
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Syncope
Clinical narrative: pt was seated and fainted apporx 5 mins after vaccine, did hit hear on ground. Pt regained consciousness right after.  Gave water and a banana and pt felt fine 10-15 minutes after. did report headache. advised to have md check him out if headache does not lessen
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: Patient fainted at front of store approximately 10 minutes after vaccine administration.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Discomfort, Fatigue, Headache, Lymphadenopathy
Clinical narrative: Chills, followed by night sweats, slight fever. (99.8) Extremely uncomfortable (my body felt like I had ?lock jaw? all over it).  Extreme fatigue, head aches, and body aches. Ended at about 10pm on Tuesday 4/27.  Wednesday 4/28 at about 6 PM I noticed I had a huge lump under my left armpit  (same arm as injection) and it felt like it was growing, went away over a week.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Night sweats, Pain, Pyrexia
Clinical narrative: Chills, followed by night sweats, slight fever. (99.8) Extremely uncomfortable (my body felt like I had ?lock jaw? all over it).  Extreme fatigue, head aches, and body aches. Ended at about 10pm on Tuesday 4/27.  Wednesday 4/28 at about 6 PM I noticed I had a huge lump under my left armpit  (same arm as injection) and it felt like it was growing, went away over a week.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Injection site pain, Malaise
Clinical narrative: Woke up next morning after dose with severe headache, mild muscle aches, chills, fatigue, injection site pain.  Symptoms worsened throughout the day to include fever of 101 degrees, worsened muscle and body aches, chills, fatigue, severe injection site pain, nausea, feeling very unwell.  Headache and muscle/body aches lasted another day after this, so total of 2 days after dose I didn't feel well, but by day 3 I was fine again.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain, Pyrexia
Clinical narrative: Woke up next morning after dose with severe headache, mild muscle aches, chills, fatigue, injection site pain.  Symptoms worsened throughout the day to include fever of 101 degrees, worsened muscle and body aches, chills, fatigue, severe injection site pain, nausea, feeling very unwell.  Headache and muscle/body aches lasted another day after this, so total of 2 days after dose I didn't feel well, but by day 3 I was fine again.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: There was no adverse event. The patient was under the age of 18 at the time of vaccination. Since she had already received one dose without incident (and her father was insistent that she be vaccinated), she was given her second dose of Moderna Covid-19 vaccine. She has had no adverse event after her second dose.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue
Clinical narrative: Patient c/o tongue swelling 10-15 minutes post vaccine.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Gout, Pain
Clinical narrative: Sudden severe painful gout in my left knee.  I went on an errand and when I was getting out of my vehicle in my garage I almost could not walk from pain.  Before that I only had untreated gout in my left foot.   I still have gout pain in my left knee while walking as of today.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic shock, Dizziness, Dysarthria, Dyspnoea, Limb discomfort
Clinical narrative: went into anaphylactic shock, couldn't breathe, tongue swelled up, light headed, legs heavy, slurred speech. Got benadryl shot at 11:49 pm, epipen at 11:58, was prescribed femotidine and prednisone.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue
Clinical narrative: went into anaphylactic shock, couldn't breathe, tongue swelled up, light headed, legs heavy, slurred speech. Got benadryl shot at 11:49 pm, epipen at 11:58, was prescribed femotidine and prednisone.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Vein disorder
Clinical narrative: Bruised almost immediately. Day 2 bruises run along vein lines. I have pictures. The vein bruising (2 veins) are approximately 2 inches per vein.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Disturbance in attention, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: Intermittent dizziness since 4pm on day of vaccine. Still continuing as of May 8 2pm. Difficulty concentrating and brain fog still continuing as of May 8 2pm. Shaking chills on and off through May 7 3pm. Fatigue through May 7 10pm.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Intermittent dizziness since 4pm on day of vaccine. Still continuing as of May 8 2pm. Difficulty concentrating and brain fog still continuing as of May 8 2pm. Shaking chills on and off through May 7 3pm. Fatigue through May 7 10pm.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient was inadvertently given second covid vaccine 20 days after first dose instead of manufacturer recommended 21 days separation.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest discomfort, Dyspnoea, Oropharyngeal discomfort
Clinical narrative: chest tightness, difficulty breathing, feeling of something stuck in her throat , weak,  patient was given EpiPen 0.3 mg 1 dose and we called 911
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine administered inadvertently to unapproved age category. Patient did not experience any reaction.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Pain, Pyrexia
Clinical narrative: Nausea- 24hours tx with zofran  Fever- 24 hours tx with ibuprofen  Body aches-24 hours tx with ibuprofen  Diarrhea- 10 hours
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Patient received vaccine, observed for 15, ambulated to the car. Husband came back to the clinic stating patient had severe vertigo. RN, LVN, and MA responded. Clear distress, eyes closed, pulse 82. States severe vertigo, no other symptoms. 911 call and EMS responded. Transported via ambulance to ED.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Mouth swelling, Pain in extremity, Palpitations, Paraesthesia
Clinical narrative: Pt c/o tingling , swelling left side of mouth, sharp left arm pain, heart racing. RN could not visualize swelling of lips/tongue. Heart rate 70's and regular. 25 PO Benadryl given. EMS notified to eval pt. EMS directed pt needs ER eval. Pt declined.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased, Cystitis, Cystoscopy normal, Electrocardiogram normal, Headache
Clinical narrative: Since receiving the first dose of the Moderna until the present day, and yet unresolved, I have suffered daily headaches, bladder infections,  lethargy, and periodic muscle aches.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Myalgia, Red blood cell sedimentation rate increased, Urinary system x-ray normal
Clinical narrative: Since receiving the first dose of the Moderna until the present day, and yet unresolved, I have suffered daily headaches, bladder infections,  lethargy, and periodic muscle aches.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Patient got home after waiting 30minutes at the pharmacy and came out in a rash on her face and neck. This occurred at 11.15am roughly. Patient has taken 3 1/2 tablets of Benadryl at the time of reporting the issue. Patient feels fine otherwise and has access to an EpiPen and lives within 5 minute distance from an urgent care.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Migraine, Monoplegia, Paraesthesia
Clinical narrative: Started with tingly fingers 20 minutes after shot that then become Numb fingers, then left side of my face started to tingle then became numb! Half my face half my nose was numb. Started 25 minutes after shot. Then by night time my left arm became paralyzed! Couldn?t move arm & fingers were numb. Next morning I could move arm from elbow down- fingers started getting feeling back. Face got feeling back but my half of nose stsyed numb another day. Then got a migraine that lasted a full week!
Age: 60.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Eustachian tube dysfunction, Eustachian tube patulous, SARS-CoV-2 test negative
Clinical narrative: Approx 1 week post vaccination symptoms of Eustachian tube dysfunction (patulous) arose.   Symptoms lasted approx 1.5 weeks before resolving.  Whether covid vaccine triggered this response is hard to say.    I also  had these identical symptoms randomly occur late June 2020,  lasting nearly 2 weeks. Saw doc, and Covid test June 30, 2020 was neg.    In  Sept 20, 2020, was seen for same issue, and tested with ENT and diagnosis was Patulous Eustachian tubes.  I had not been sick with covid, that I am/was ever aware of,  or experienced any other influenza symptoms, or even a sniffle since Feb 2017.      Is it possible I was potentially covid pos, and just asymptomatic, when these symptoms  initially presented, and 1-1/2 weeks later in a doc appt no long  pos on a covid test result?   Looking back perhaps an anti body test may have been more conclusive.   In  months prior,  Jan-Feb 2020, I was around  a few folks that were sick, but not diagnosed with covid, as there was not any covid testing at that time... possible, just not conclusive.    But, now left with Patulous symptoms, unexplained and unresolved.  Either way, I am now having onset of Patulous Eustachian Tube disorder symptoms, randomly triggered, as an adult.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Injection site nodule, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: I had a large, hard knot on my arm near the injection site that appeared 7 days after receiving the vaccine. I experienced soreness and mild itchiness at the site. I did not take any medication for pain or swelling. About 12 hours after it appeared the swelling had mostly subsided, the site was still hard, and mild soreness remained. The swelling and soreness is almost entirely gone 2 days later.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dysstasia, Fatigue, Heavy menstrual bleeding, Menstruation irregular, Pain
Clinical narrative: Effect 1: About a week(5 days or so) severe pain in left leg from the knee down and ankle. Severe as in can?t stand the pain and feels like the leg from the knee down to ankle was being cut off.  Effect 2: got my period 7 days after the vaccine was given and it hasn?t gone away. Heavy bleeding and fatigue. I typically don?t get a period and am irregular so this is not normal for me personally.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Effect 1: About a week(5 days or so) severe pain in left leg from the knee down and ankle. Severe as in can?t stand the pain and feels like the leg from the knee down to ankle was being cut off.  Effect 2: got my period 7 days after the vaccine was given and it hasn?t gone away. Heavy bleeding and fatigue. I typically don?t get a period and am irregular so this is not normal for me personally.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Seizure
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Nausea-Medium, Systemic: Seizure-Medium
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: vaccine inadvertently administered to patient. Pt experienced no adverse reaction.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: chronic minor tinnitus
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Headache, Hot flush, Pain, Pyrexia
Clinical narrative: Fever, hot and cold flashes, body aches, headache
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Infection, Pyrexia
Clinical narrative: Fever, infection and hospitalization
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood chloride decreased, Blood creatinine normal, Blood glucose normal, Blood potassium normal
Clinical narrative: Within 1 hour of the vaccination, patient developed headache (lasted 2-3 days), and 1 week of nausea, intermittent vomiting, extreme fatigue, generalized weakness.  He had decreased oral intake for solids and liquids, up to 5-6 total episodes of emesis over the last week.  He was seen in urgent care 5/5 and treated with Zofran.  He had decreased urine output the next two days (~15 hours without voiding). And was seen in ED 5/7 and transferred to ICU for management of severe hyponatremia, though never developed seizures or neurologic abnormalities.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium decreased, Blood urea increased, Carbon dioxide decreased, Fatigue, Headache
Clinical narrative: Within 1 hour of the vaccination, patient developed headache (lasted 2-3 days), and 1 week of nausea, intermittent vomiting, extreme fatigue, generalized weakness.  He had decreased oral intake for solids and liquids, up to 5-6 total episodes of emesis over the last week.  He was seen in urgent care 5/5 and treated with Zofran.  He had decreased urine output the next two days (~15 hours without voiding). And was seen in ED 5/7 and transferred to ICU for management of severe hyponatremia, though never developed seizures or neurologic abnormalities.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Hyponatraemia, Hypophagia, Intensive care, Nausea, SARS-CoV-2 test negative
Clinical narrative: Within 1 hour of the vaccination, patient developed headache (lasted 2-3 days), and 1 week of nausea, intermittent vomiting, extreme fatigue, generalized weakness.  He had decreased oral intake for solids and liquids, up to 5-6 total episodes of emesis over the last week.  He was seen in urgent care 5/5 and treated with Zofran.  He had decreased urine output the next two days (~15 hours without voiding). And was seen in ED 5/7 and transferred to ICU for management of severe hyponatremia, though never developed seizures or neurologic abnormalities.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Urine output decreased, Vomiting
Clinical narrative: Within 1 hour of the vaccination, patient developed headache (lasted 2-3 days), and 1 week of nausea, intermittent vomiting, extreme fatigue, generalized weakness.  He had decreased oral intake for solids and liquids, up to 5-6 total episodes of emesis over the last week.  He was seen in urgent care 5/5 and treated with Zofran.  He had decreased urine output the next two days (~15 hours without voiding). And was seen in ED 5/7 and transferred to ICU for management of severe hyponatremia, though never developed seizures or neurologic abnormalities.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient was inadvertently given second Pfizer covid vaccine 20 days after first dose instead of manufacturer recommended 21 days separation
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site hypoaesthesia
Clinical narrative: Systemic: complaints of numbness in injected arm and side of face  lasted 5 hours and then subsided-Medium, Additional Details: Contacted patient the following day and he reported feeling fine.  Was getting ready to go to work.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Diplopia, Dizziness, Loss of consciousness, Nausea, Seizure
Clinical narrative: The patient received the Janssen Johnson & Johnson vaccine from a certified immunizing technician. She was asked to wait 15 minutes after receiving the vaccine before leaving the pharmacy and remained seated in the post vaccination waiting area chair. She began feeling dizzy and lightheaded. She was caught by her family members and the pharmacist on duty before she fell. She briefly had a mild seizure and lost consciousness for a minute. When she regained consciousness she stated that she felt nauseous and was seeing double. 911 was called. EMTs arrived and checked her alertness and how she was feeling. The EMTs then took her off in a stretcher to the hospital out of an abundance of caution due to brief loss of consciousness.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Injection site pruritus, Injection site rash, Injection site swelling, Lymphadenopathy
Clinical narrative: An itchy and sometimes tingly swollen welt/rash at the location of the injection. Firm to touch and about an inch and a half in diameter.  Additionally a swollen lymph node along the collarbone.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: An itchy and sometimes tingly swollen welt/rash at the location of the injection. Firm to touch and about an inch and a half in diameter.  Additionally a swollen lymph node along the collarbone.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Moderna vaccine not indicated for patient under 18 was given to 17 year old
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site paraesthesia
Clinical narrative: tingling all down injected arm
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling cold, Headache, Migraine, Myalgia
Clinical narrative: Chills, headache, muscle aches, fever, nausea  Felt cold at  3:30 pm, 4/30/2021- mild muscle aches began, by 7:00 pm began having significant chills lasting till  midnight.  Took OTC ibuprofen to reduce mitigate chills and headache.   5/1/21 - still getting  headache/migraine.  12:00 pm Chills and achiness gone.  No nausea at that time.  4/30 2021 to current 5/8/2021 still getting daily headaches and migraines primarily from back of neck and head to forehead. Taking OTC ibuprofen and Maxalt melt  for relief.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia
Clinical narrative: Chills, headache, muscle aches, fever, nausea  Felt cold at  3:30 pm, 4/30/2021- mild muscle aches began, by 7:00 pm began having significant chills lasting till  midnight.  Took OTC ibuprofen to reduce mitigate chills and headache.   5/1/21 - still getting  headache/migraine.  12:00 pm Chills and achiness gone.  No nausea at that time.  4/30 2021 to current 5/8/2021 still getting daily headaches and migraines primarily from back of neck and head to forehead. Taking OTC ibuprofen and Maxalt melt  for relief.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Nausea, Pallor, Tremor
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Medium, Systemic: Shakiness-Mild, Systemic: Vomiting-Medium, Systemic: Weakness-Mild, Additional Details: Within a few minutes after receiving second dose, she threw up and was very pale. She was drinking water and we got her crackers and candy. She laid down on the floor for about 10 minutes and started to vomit again. I asked her dad if he would prefer me to call an ambulance to have her checked out. He said yes so they were called. Her vitals were good when they checked her when they got here. They did take her to the hospital.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Medium, Systemic: Shakiness-Mild, Systemic: Vomiting-Medium, Systemic: Weakness-Mild, Additional Details: Within a few minutes after receiving second dose, she threw up and was very pale. She was drinking water and we got her crackers and candy. She laid down on the floor for about 10 minutes and started to vomit again. I asked her dad if he would prefer me to call an ambulance to have her checked out. He said yes so they were called. Her vitals were good when they checked her when they got here. They did take her to the hospital.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Headache, Menstruation delayed, Pregnancy test negative
Clinical narrative: Got the 1st COVID vaccine on 4/13/2021. Had a headache on 4/14/2021 for just one day.  No other symptoms  until 4/17/2021. Since that day I began to  have mild menstrual pain everyday from 4/17/2021 - 5/4/2021. (about 3 weeks) The pain level is about 2-3 and I experience a peak on  5/3 and 5/4  then it suddenly stops. My period should start on 5/3 however still didnt have it.(Have been late for 5 days and no signs that it will come at all). Had multiple pregnancy tests, all negative.